JP2005511608A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511608A5
JP2005511608A5 JP2003542177A JP2003542177A JP2005511608A5 JP 2005511608 A5 JP2005511608 A5 JP 2005511608A5 JP 2003542177 A JP2003542177 A JP 2003542177A JP 2003542177 A JP2003542177 A JP 2003542177A JP 2005511608 A5 JP2005511608 A5 JP 2005511608A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
hydrogen
aryl
alkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003542177A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/012164 external-priority patent/WO2003040131A1/en
Publication of JP2005511608A publication Critical patent/JP2005511608A/ja
Publication of JP2005511608A5 publication Critical patent/JP2005511608A5/ja
Pending legal-status Critical Current

Links

JP2003542177A 2001-11-07 2002-10-31 アミノピリミジン類及び−ピリジン類 Pending JP2005511608A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33831201P 2001-11-07 2001-11-07
PCT/EP2002/012164 WO2003040131A1 (en) 2001-11-07 2002-10-31 Aminopyrimidines and pyridines

Publications (2)

Publication Number Publication Date
JP2005511608A JP2005511608A (ja) 2005-04-28
JP2005511608A5 true JP2005511608A5 (enExample) 2006-01-05

Family

ID=23324288

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003542177A Pending JP2005511608A (ja) 2001-11-07 2002-10-31 アミノピリミジン類及び−ピリジン類

Country Status (12)

Country Link
US (2) US6846828B2 (enExample)
EP (1) EP1444223A1 (enExample)
JP (1) JP2005511608A (enExample)
KR (1) KR20050042062A (enExample)
CN (1) CN1582284A (enExample)
AR (1) AR039554A1 (enExample)
BR (1) BR0213899A (enExample)
CA (1) CA2465711A1 (enExample)
MX (1) MXPA04004166A (enExample)
PL (1) PL370480A1 (enExample)
RU (1) RU2308455C2 (enExample)
WO (1) WO2003040131A1 (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021726D0 (en) * 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0205688D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
JP2005524672A (ja) * 2002-03-09 2005-08-18 アストラゼネカ アクチボラグ Cdk阻害活性を有するイミダゾリル置換ピリミジン誘導体
GB0205690D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
CA2502429A1 (en) 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
CN100441569C (zh) * 2003-02-24 2008-12-10 横滨橡胶株式会社 化合物和使用了该化合物的组合物
GB0311276D0 (en) * 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0311274D0 (en) * 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
BRPI0415390A (pt) * 2003-10-14 2006-12-12 Pharmacia Corp compostos de pirazinona substituìda para o tratamento da inflamação
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
TW200528101A (en) * 2004-02-03 2005-09-01 Astrazeneca Ab Chemical compounds
SI1809624T1 (sl) * 2004-08-28 2014-02-28 Astrazeneca Ab Derivati pirimidinsulfonamida kot modulatorji receptorja kemokina
AU2005315392B2 (en) * 2004-12-17 2010-03-11 Astrazeneca Ab 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
GB0514017D0 (en) * 2005-07-07 2005-08-17 Ionix Pharmaceuticals Ltd Chemical compounds
EP2301928A1 (en) * 2005-07-30 2011-03-30 AstraZeneca AB Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
US7745428B2 (en) * 2005-09-30 2010-06-29 Astrazeneca Ab Imidazo[1,2-A]pyridine having anti-cell-proliferation activity
AR058277A1 (es) * 2005-12-09 2008-01-30 Solvay Pharm Gmbh N- sulfamoil - piperidin - amidas, composiciones farmaceuticas que las comprenden y procedimiento para su preparacion
TW200811169A (en) * 2006-05-26 2008-03-01 Astrazeneca Ab Chemical compounds
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain
CA2782320A1 (en) * 2009-12-02 2011-06-09 Acceleron Pharma Inc. Compositions and methods for increasing serum half-life of fc fusion proteins
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
WO2012170938A1 (en) 2011-06-08 2012-12-13 Acceleron Pharma Inc. Compositions and methods for increasing serum half-life
UA125503C2 (uk) 2012-06-13 2022-04-13 Інсайт Холдинґс Корпорейшн Заміщені трициклічні сполуки як інгібітори fgfr
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
MY181497A (en) 2013-04-19 2020-12-23 Incyte Holdings Corp Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
CR20170390A (es) 2015-02-20 2017-10-23 Incyte Holdings Corp Heterociclos biciclicos como inhibidores de fgfr
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
US11427556B2 (en) 2017-11-17 2022-08-30 Hepagene Therapeutics (HK) Limited Urea derivatives as inhibitors of ASK1
PE20210919A1 (es) 2018-05-04 2021-05-19 Incyte Corp Sales de un inhibidor de fgfr
BR112020022392A2 (pt) 2018-05-04 2021-02-02 Incyte Corporation formas sólidas de um inibidor de fgfr e processos para preparação das mesmas
KR102441327B1 (ko) * 2018-05-18 2022-09-07 주식회사유한양행 다이아미노피리미딘 유도체 또는 이의 산부가염의 신규의 제조방법
CN109336800B (zh) * 2018-09-17 2022-11-29 江西中医药大学 一种dhnb缩苯基氨基硫脲化合物及其制备方法和用途
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
GEP20247679B (en) 2019-10-14 2024-10-10 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
JP7720840B2 (ja) 2019-12-04 2025-08-08 インサイト・コーポレイション Fgfr阻害剤としての三環式複素環
PE20221504A1 (es) 2019-12-04 2022-09-30 Incyte Corp Derivados de un inhibidor de fgfr
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
TW202304459A (zh) 2021-04-12 2023-02-01 美商英塞特公司 包含fgfr抑制劑及nectin-4靶向劑之組合療法
CA3220155A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
TW202313611A (zh) 2021-06-09 2023-04-01 美商英塞特公司 作為fgfr抑制劑之三環雜環
CN115919864B (zh) * 2022-12-02 2024-09-03 中南大学湘雅三医院 唑嘧啶胺类化合物在用于制备治疗ibd药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095240A (en) * 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
DE59106752D1 (de) 1990-05-16 1995-11-30 Sulzer Chemtech Ag Verfahren zur gerichteten fraktionierten Kristallisation.
EP0457727A1 (de) * 1990-05-17 1991-11-21 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
IL106786A (en) * 1992-09-10 1997-02-18 Basf Ag Substituted pyridine derivatives and fungicidal compositions containing them
JP3398152B2 (ja) * 1993-10-12 2003-04-21 ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー 1n−アルキル−n−アリールピリミジンアミンおよびその誘導体
ES2250363T3 (es) * 2000-02-02 2006-04-16 Dorian Bevec Guanilhidrazonas aromaticas farmaceuticamente activas.
PL366114A1 (en) 2000-10-26 2005-01-24 Tularik Inc. Antiinflammation agents

Similar Documents

Publication Publication Date Title
JP2005511608A5 (enExample)
RU2004117545A (ru) Аминопиримидины и пиридины
CN100355751C (zh) 2-取代的4-杂芳基-嘧啶、其组合物及其用途
JP6193922B2 (ja) ハロアルキルヘテロアリールベンズアミド化合物
US6924302B2 (en) Substituted triazole diamine derivatives as kinase inhibitors
JP2568315B2 (ja) 縮合環アリール置換イミダゾール
DE08851028T1 (de) Verwendung von crth2-antagonisten-verbindungen
RU2007146798A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JP2007504160A5 (enExample)
EA016887B1 (ru) ЗАМЕЩЁННЫЕ ФЕНОКСИАМИНОТИАЗОЛОНЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ РОДСТВЕННОГО ЭСТРОГЕНОВОМУ РЕЦЕПТОРУ РЕЦЕПТОРА-α
JP2005526028A5 (enExample)
JP2002505690A (ja) 新規なアリールオキシピリミジン置換イミダゾール化合物
JP2002528506A (ja) ピリジン−4−イルまたはピリミジン−4−イル置換ピラジン
EA029718B1 (ru) Бифтордиоксалан-аминобензимидазольные ингибиторы киназы для лечения рака, аутоиммунного воспаления и нарушений цнс
CA2720176A1 (en) Antiproliferative compounds and therapeutic uses thereof
JP2001518507A (ja) 新規シクロアルケニル置換化合物
AU2005221131A1 (en) Ion channel modulators
CA2617991A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
CA2557650A1 (en) Ion channel modulators
AU2005231123A1 (en) Ion channel modulators
CA3157778A1 (en) Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same
CA2558217A1 (en) Ion channel modulators
JPWO2019213570A5 (enExample)
JP2008517907A5 (enExample)
JP5872591B2 (ja) ピラゾール化合物